CRSP
Crispr Therapeutics AG
55.80$
-5.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 2.46 | 0.01 | 0.01 | 0.01 | 0.41 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.11 | 0.14 | |
| 0.29 | 0.25 | 0.63 | 0.67 | 0.19 | 0.05 | 0.67 | 0.57 | 0.71 | 0.66 | 0.52 | 0.46 | 2.27 | |
| -0.29 | 2.21 | -0.63 | -0.66 | -0.18 | 0.41 | -0.66 | -0.56 | -0.70 | -0.65 | -0.51 | -0.36 | -2.13 | |
| 1.14 | 1.17 | 0.87 | 0.89 | 0.91 | 0.96 | 0.84 | 0.75 | 0.65 | 0.87 | 0.71 | 0.67 | 2.80 | |
| 0.23 | 0.20 | 0.22 | 0.23 | 0.20 | 0.21 | 0.22 | 0.22 | 0.19 | 0.20 | 0.18 | 0.18 | 0.73 | |
| 1.37 | 1.36 | 1.09 | 1.12 | 1.11 | 1.17 | 1.07 | 0.97 | 0.75 | 1.07 | 0.85 | 0.83 | 3.38 | |
| -1.67 | 0.86 | -1.72 | -1.78 | -1.29 | -0.76 | -1.73 | -1.53 | -1.45 | -1.72 | -1.36 | -1.19 | -5.51 | |
| – | 0.22 | – | – | – | – | – | – | – | – | – | – | – | |
| -1.41 | 1.10 | -1.42 | -1.47 | -1.00 | -0.43 | -1.57 | -2.38 | -1.16 | -1.45 | -1.27 | -0.93 | -4.64 | |
| 0.01 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | |
| -1.41 | 1.10 | -1.43 | -1.49 | -1.01 | -0.44 | -1.58 | -2.40 | -1.17 | -1.45 | -1.28 | -0.94 | -4.67 | |
| -1.35 | 1.16 | -1.36 | -1.42 | -0.94 | -0.37 | -1.51 | -2.33 | -1.11 | -1.38 | -1.23 | -1.14 | -4.70 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.